BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Europabio - ECPv6.15.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Europabio
X-ORIGINAL-URL:https://www.europabio.org
X-WR-CALDESC:Events for Europabio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260603T080000
DTEND;TZID=Europe/Brussels:20260604T200000
DTSTAMP:20260727T222722
CREATED:20260113T081624Z
LAST-MODIFIED:20260113T081823Z
UID:9392-1780473600-1780603200@www.europabio.org
SUMMARY:ECRD 2026: Rare Diseases in a changing & Competitive Europe
DESCRIPTION:ECRD is the largest\, patient-led policy-shaping conference for rare diseases in Europe. The event is an instrumental tool for advancing policy objectives that improve the lives of people living with a rare disease. The overarching title of ECRD 2026 is: Rare Diseases in a Changing & Competitive Europe: Shaping policies to address the unmet needs of people living with rare diseases.  \n\n\n\nRare disease research has long driven breakthroughs in more common conditions\, reinforcing Europe’s role as a global leader in biotechnology and precision medicine. Investing in this field is not only a moral imperative—it is a strategic move to boost Europe’s competitiveness in the life sciences. This is especially crucial in the context of the deployment of the Life Science Strategy and of the adoption of the Biotech Act.  \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/ecrd-2026-rare-diseases-in-a-changing-competitive-europe/
CATEGORIES:External,Healthcare Biotech,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/01/Event-Banners-Website-32.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260611T090000
DTEND;TZID=Europe/Brussels:20260611T133000
DTSTAMP:20260727T222722
CREATED:20260424T102431Z
LAST-MODIFIED:20260424T102433Z
UID:9607-1781168400-1781184600@www.europabio.org
SUMMARY:European Biotech Forum 2026
DESCRIPTION:EuropaBio is a proud sponsor of the European Biotech Forum 2026. \n\n\n\nBiotechnology is becoming a decisive capability for Europe’s competitiveness\, industrial resilience and strategic autonomy. But Europe enters the next institutional cycle with a fragmented policy landscape\, uneven regulatory capacity\, and persistent scale-up barriers. The Commission’s Biotech Communication I and Biotech Communication II set out an initial toolbox\, but fall short of an end-to-end industrial framework comparable to the US. The gap between ambition and execution remains significant. To what extent do these communications address the core challenges of Europe’s biotech sector? Where are the structural gaps that still block growth and industrial deployment? \n\n\n\n\nMore Info & Registration Here
URL:https://www.europabio.org/event/european-biotech-forum-2026/
CATEGORIES:EuropaBio,External,Healthcare Biotech,Industrial Biotech,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/04/Event-Banners-Website-1-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260625T130000
DTEND;TZID=Europe/Brussels:20260625T140000
DTSTAMP:20260727T222722
CREATED:20260622T132337Z
LAST-MODIFIED:20260622T132339Z
UID:9699-1782392400-1782396000@www.europabio.org
SUMMARY:Preparing for scale: industrial readiness and infrastructure access
DESCRIPTION:APROVALS Webinar Series – Public Session \n\n\n\nThis is the first session of the APROVALS public webinar series\, a programme of collective learning events open to companies participating in the project and to the broader industrial ecosystem. \n\n\n\nAPROVALS webinars are designed to go beyond individual sandbox sessions: they create a shared space where companies can compare experiences\, discuss cross-cutting challenges\, and engage with external experts on the topics that matter most to scaling innovative technologies. \n\n\n\nSession #1 – Preparing for scale: industrial readiness and infrastructure access \n\n\n\nOne of the most strategic — and most frequently asked — questions among APROVALS participants: how do you know when you are ready to move from pilot to industrial scale? \n\n\n\nThis session will explore: \n\n\n\n\nThe key signals and criteria that indicate readiness for industrialisation\n\n\n\nCommon bottlenecks companies face when scaling from lab or pilot to full production\n\n\n\nFrameworks and options available to navigate this transition in a structured way\n\n\n\n\nWe’ll discuss with: \n\n\n\nRob Kooijmans (Food Safety) \n\n\n\nReza Ranjbar (AartinBio) \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/preparing-for-scale-industrial-readiness-and-infrastructure-access/
CATEGORIES:External,Industrial Biotech,National Associations,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/06/Event-Banners-Website-6.png
END:VEVENT
END:VCALENDAR